Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-06 00:20 | 2025-05-02 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $15.19 | 11,448 | $173,917 | 913,795 | -1.2% |
| 2025-03-26 23:41 | 2025-03-24 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $17.55 | 3,671 | $64,414 | 925,243 | -0.4% |
| 2025-03-21 01:27 | 2025-03-17 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $17.61 | 1,200 | $21,137 | 928,914 | -0.1% |
| 2025-03-05 03:43 | 2025-03-03 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $13.07 | 25,015 | $327,019 | 930,114 | -2.6% |
| 2025-02-05 04:01 | 2025-02-03 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $12.70 | 19,301 | $245,123 | 804,129 | -2.3% |
| 2024-12-24 03:22 | 2024-12-20 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $15.17 | 15,000 | $227,567 | 823,430 | -1.8% |
| 2024-12-04 00:16 | 2024-05-31 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | BUY | $3.52 | 6,038 | $21,250 | 838,430 | +0.7% |
| 2024-11-06 00:46 | 2024-11-04 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $8.68 | 13,871 | $120,459 | 832,392 | -1.6% |
| 2024-08-05 23:37 | 2024-08-02 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $9.02 | 14,487 | $130,648 | 846,263 | -1.7% |
| 2024-05-03 23:22 | 2024-05-02 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $8.74 | 13,783 | $120,433 | 860,750 | -1.6% |
| 2024-03-07 01:09 | 2024-03-04 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $11.12 | 14,903 | $165,739 | 874,533 | -1.7% |
| 2024-03-02 00:11 | 2024-02-28 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $10.60 | 2,465 | $26,129 | 889,436 | -0.3% |
| 2023-12-02 04:51 | 2023-05-31 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | BUY | $6.38 | 1,463 | $9,334 | 515,145 | +0.3% |
| 2023-03-09 00:29 | 2023-03-06 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $15.26 | 2,435 | $37,167 | 366,657 | -0.7% |
| 2023-03-03 03:06 | 2023-02-28 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $15.93 | 7,815 | $124,484 | 369,092 | -2.1% |
| 2023-02-16 03:09 | 2023-02-13 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $17.01 | 1,000 | $17,012 | 376,907 | -0.3% |
| 2023-02-04 00:26 | 2023-02-01 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $17.00 | 1,000 | $17,003 | 377,907 | -0.3% |
| 2022-12-10 00:47 | 2022-12-07 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $17.06 | 1,000 | $17,060 | 378,907 | -0.3% |
| 2022-11-10 00:39 | 2022-11-07 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $18.00 | 1,000 | $18,004 | 379,907 | -0.3% |
| 2022-10-12 01:47 | 2022-10-07 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | SALE | $19.51 | 1,000 | $19,510 | 380,907 | -0.3% |
| 2022-09-10 00:10 | 2022-09-07 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | SALE | $21.51 | 1,000 | $21,510 | 381,907 | -0.3% |
| 2022-08-10 00:16 | 2022-08-05 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $24.74 | 2,500 | $61,858 | 651,871 | -0.4% |
| 2022-07-13 02:30 | 2022-07-08 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $25.37 | 13,500 | $342,473 | 651,871 | -2.0% |
| 2022-07-07 23:04 | 2022-07-06 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | SALE | $22.07 | 1,000 | $22,070 | 658,284 | -0.2% |
| 2022-06-06 23:06 | 2022-06-06 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | SALE | $21.06 | 1,000 | $21,064 | 659,284 | -0.2% |
| 2022-05-06 00:31 | 2022-05-05 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | SALE | $21.76 | 1,000 | $21,760 | 658,667 | -0.2% |
| 2022-04-06 01:45 | 2022-04-05 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | SALE | $21.43 | 1,000 | $21,430 | 659,667 | -0.2% |
| 2022-03-12 05:42 | 2022-03-09 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | SALE | $17.00 | 300 | $5,100 | 660,667 | 0.0% |
| 2022-03-08 04:59 | 2022-03-04 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $16.90 | 3,259 | $55,088 | 660,967 | -0.5% |
| 2022-03-04 00:18 | 2022-03-01 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | SALE | $17.75 | 2,153 | $38,222 | 592,626 | -0.4% |
| 2022-02-12 01:55 | 2022-02-09 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $17.00 | 1,000 | $17,000 | 594,779 | -0.2% |
| 2022-01-08 00:17 | 2022-01-05 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $21.59 | 1,000 | $21,592 | 594,779 | -0.2% |
| 2021-12-11 02:41 | 2021-12-08 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $17.00 | 1,000 | $17,000 | 594,779 | -0.2% |
| 2021-11-10 01:19 | 2021-11-05 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $21.50 | 1,000 | $21,502 | 594,779 | -0.2% |
| 2021-10-07 23:05 | 2021-10-05 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $24.92 | 2,500 | $62,294 | 594,779 | -0.4% |
| 2021-10-05 21:10 | 2021-10-01 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $25.01 | 1,500 | $37,510 | 594,779 | -0.3% |
| 2021-09-10 00:42 | 2021-09-07 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $21.14 | 1,000 | $21,137 | 594,779 | -0.2% |
| 2021-08-10 01:51 | 2021-08-05 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $20.81 | 1,000 | $20,810 | 594,779 | -0.2% |
| 2021-07-09 02:40 | 2021-07-06 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $26.58 | 1,750 | $46,515 | 594,779 | -0.3% |
| 2021-06-09 23:35 | 2021-06-07 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $26.35 | 1,750 | $46,113 | 594,779 | -0.3% |
| 2021-05-11 18:47 | 2021-05-07 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $35.00 | 750 | $26,250 | 593,773 | -0.1% |
| 2021-05-07 18:29 | 2021-05-05 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $34.00 | 1,750 | $59,500 | 593,773 | -0.3% |
| 2021-05-04 22:00 | 2021-04-30 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | SALE | $35.00 | 1,500 | $52,500 | 593,916 | -0.3% |
| 2021-04-07 00:30 | 2021-04-05 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | SALE | $29.93 | 1,750 | $52,378 | 595,416 | -0.3% |
| 2021-03-05 23:56 | 2021-03-05 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | SALE | $30.55 | 1,750 | $53,463 | 597,166 | -0.3% |
| 2021-03-04 00:51 | 2021-03-02 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | SALE | $35.19 | 2,107 | $74,136 | 566,216 | -0.4% |
| 2021-02-09 00:00 | 2021-02-05 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $34.29 | 10,000 | $342,916 | 568,323 | -1.7% |
| 2021-01-07 23:13 | 2021-01-05 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $28.08 | 10,000 | $280,754 | 568,323 | -1.7% |
| 2020-10-02 04:02 | 2020-09-29 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $30.00 | 3,000 | $90,000 | 566,928 | -0.5% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.